Advertisement

Topics

Latest "Reference Laboratory Focus Diagnostics, Inc." News Stories

21:08 EST 12th December 2018 | BioPortfolio

Here are the most relevant search results for "Reference Laboratory Focus Diagnostics, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Reference Laboratory Focus Diagnostics, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Reference Laboratory Focus Diagnostics, Inc. for you to read. Along with our medical data and news we also list Reference Laboratory Focus Diagnostics, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Reference Laboratory Focus Diagnostics, Inc. Companies for you to search.

Showing "Reference Laboratory Focus Diagnostics" News Articles 1–25 of 9,600+

Wednesday 12th December 2018

Stream Bio launches new range of Streptavidin-linked CPNs

Stream Bio, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, has launched its new range of Streptavidin-linked CPNs™ onto the market. These Streptavidin Conjugates can be used for the detection of various biomolecules and will complement Stream’s current portfolio of CPN™ molecular probes. Stream Bio’s CPNs™ have applicati...


MicroRNA amplification and detection technologies: opportunities and challenges for point of care diagnostics

Powles Navigates Rapidly Evolving Frontline Paradigm in Urothelial Carcinoma

Thomas Powles MBBS, MRCP, MD, discusses the changes to the frontline landscape of bladder cancer and where research should focus moving forward.


The Medicines Company Announces Intention to Offer $150 Million of Convertible Notes

The Medicines Company (NASDAQ:MDCO) (the “Company”) today announced that it proposes to offer $150 million aggregate principal amount of convertible senior notes due 2024, subject to market conditions and other factors. The notes are to be offered and sold only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as...

Five Prime Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced that Aron Knickerbocker, Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference, Wednesday, January 9, 2019 at

Ophthotech Announces the Addition of Ophthalmic Industry Leader, Adrienne L. Graves, Ph.D., Former Chief Executive Officer of Santen Inc., to Its Board of Directors

Ophthotech Corporation (NASDAQ:OPHT) announced today the election of Adrienne L. Graves, Ph.D., former Chief Executive Officer of Santen Inc., the U.S. arm of Japan’s largest ophthalmic pharmaceutical company, to its Board of Directors, effective immediately. Dr. Graves is well-known in the ophthalmology community and for her successful track record in b...

Friendly Electromagnetic Pulse Improves Survival for Electronics

NewsThe ElectroMagnetic Environment Simulator, or EMES, consists of a hippopotamus-sized Marx generator that sits alone in a small laboratory.

Sekisui Diagnostics LLC Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummarySekisui Diagnostics LLC Sekisui Diagnostics, a subsidiary of Sekisui Chemical Co Ltd, is a medical device company that develops, manufactures and supplies clinical diagnostic and research products. The company provides products such as coagulation, clinical chemistry, virotech products, OSOM rapid tests and enzymes, among others. It provides clinical chemistry products such as acetaminophen...

FDA issues new guidances to advance biosimilars

Entries Still Being Accepted for Lab of the Year

NewsEnter for your chance to be a part of Laboratory Design history!Staff Author: 

Brident Dental Enters into First-of-Its-Kind, Value-Based Contract in Texas

Agreement with DentaQuest under Alternative Payment Model supports Brident Dental’s goal of patient-centric care Brident Dental & Orthodontics, an affiliate of Western Dental, one of the nation’s largest dental providers and the leader in accessible, affordable oral healthcare, has entered into a first-of-its-kind agreement in Texas to particip...

Data Integrity Guidance Adds Focus On Culture, Best Practices And APIs

In response to comments, US FDA’s final guidance on data integrity further refines and expands on some of the principles...   

FDA Data Integrity Guidance Adds Focus On Culture, Best Practices And APIs

In response to comments, FDA’s final guidance on data integrity further refines and expands on some of the principles and...   

CDISC and Cohen Veterans Bioscience Announce Release of First Data Standard to Improve Research for Post Traumatic Stress Disorder

CDISC and Cohen Veterans Bioscience are pleased to announce the publication of a new Therapeutic Area (TA) Standard for Post Traumatic Stress Disorder released in the form of a User Guide for data managers, statisticians, programmers and study managers. PTSD is a clinically diagnosed psychiatric condition that can occur follow

Undercover Colors Debuts SipChip™, the Most Comprehensive Date Rape Drug Detection Device Designed for Personal Use

SipChip™ Helps Combat Drug-Facilitated Sexual Assault by Detecting Spiked Beverages In September, Undercover Colors introduced the most comprehensive date rape drug detection device designed for personal use – thanks to its portability, small size, and ability to detect beverages spiked with drugs (commonly called roofies) in as little as...

Turn-Key Health Demonstrates Evidence of Practice with National Consensus Project’s Clinical Practice Guidelines for Quality Palliative Care, 4th Edition

Guidelines emphasize the importance of interdisciplinary care and care coordination as patients move across care settings. Turn-Key Health (TKH), an Enclara Healthcare company, announces its home-based

Geneva Health Solutions Hits Critical Milestones Driving Growth; Predicts Cardiac Data Explosion in 2019

Geneva Health Solutions (GHS), the leading cloud-based technology platform and service for managing data from implantable cardiac devices, announces triple-digit revenue growth in 2018, an indicator of the explosive growth of implantable cardiac device data expected in 2019. This year, GHS has also tripled its client base and workforce, quadrupled t...

Architecture and Productivity: Four Theses

I certainly enjoyed this review of a new book, Laboratory Lifestyles, in Nature. This is a look at research buildings and the behavior of scientists in them, and will for many reopen a lot of arguments. Open offices? Open-plan lab space? Where do the break areas go, and the conference rooms? What do they look

Horizon Healthcare Services, Inc. Turns to Kentmere Healthcare Consulting Corporation to Expand Outpatient Laboratory Network

Kentmere Healthcare Consulting Corporation of Wilmington, Del. said today that Horizon Healthcare Services, Inc., New Jersey’s oldest and largest health insurer, utilized its services to evaluate, analyze and optimize their outpatient laboratory provider network. Kentmere Healthcare Consulting also was retained to review and ensure the appropriate use of...

Ascend Cares Volunteers Build and Donate Playhouses to Children with Disabilities

The Ascend Cares Foundation, a nonprofit organization funded and led by employees of Ascend Performance Materials, announced today the building and donation of 10 playhouses to children with disabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181212005583/en/ A BACH client sees his custom-bui...

Generex Biotechnology Receives IND Approval from FDA for Phase II Combination Study using AE37 plus Keytruda® (pembrolizumab) for the Treatment of Triple Negative Breast Cancer

Generex Biotechnology Corporation (OTCQB:GNBT) today announced that the FDA had reviewed the company’s investigational new drug (IND) application and given notification that the study can proceed. The study: A Phase II Clinical Trial of Pembrolizumab (Keytruda®) in Combination with the AE37 Peptide Vaccine in Patients with Metastatic Triple Negative Bre...

NextGen Healthcare Celebrates 40 Years of Dental Technology Leadership

QSIDental® has supported more than 100 thousand dental professionals since 1978 NextGen Healthcare, Inc. (NASDAQ:NXGN), the leading provider of ambulatory-only healthcare technology solutions, recognizes a milestone of 40 years supporting dental professionals by providing electronic dental records (EDR) and practice management (PM) solutions. T...

Comparison of reference Infliximab and a Biosimilar (CT-P13) in Crohn's Disease (CME/CE)

(MedPage Today) -- Analysis of real-world data show that CT-P13 is equivalent to infliximab in infliximab-naive patients with CD

MD Magazine® Expands Strategic Alliance Partnership Program with the University of New Mexico Health Sciences Center

The partners will collaborate to help improve health care in New Mexico MD Magazine®, a digital portal focused on providing physicians with the most valuable, up-to-date specialty and disease-specific resources to help them provide the best patient care, welcomes the University of New Mexico Health Sciences Center (UNM HSC) to its Strategic All...

'Reined-In' US Diagnostics Legislation Adds Pre-Certification, Other Updates

A revised bill is circulating in both the US House and Senate to revamp FDA regulation of diagnostics. It would...   


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks